Literature DB >> 25903036

Inappropriate benzodiazepine use in elderly patients and its reduction.

Cara Tannenbaum1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25903036      PMCID： PMC4409441          DOI： 10.1503/jpn.140355

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  17 in total

Review 1.  American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2012-02-29       Impact factor: 5.562

Review 2.  Sleep and hormonal changes in aging.

Authors:  Georges Copinschi; Anne Caufriez
Journal:  Endocrinol Metab Clin North Am       Date:  2013-03-29       Impact factor: 4.741

Review 3.  Chronic insomnia.

Authors:  Charles M Morin; Ruth Benca
Journal:  Lancet       Date:  2012-01-20       Impact factor: 79.321

Review 4.  A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs.

Authors:  Cara Tannenbaum; Amélie Paquette; Sarah Hilmer; Jayna Holroyd-Leduc; Ryan Carnahan
Journal:  Drugs Aging       Date:  2012-08-01       Impact factor: 3.923

5.  Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults.

Authors:  Kristina Zint; Walter E Haefeli; Robert J Glynn; Helen Mogun; Jerry Avorn; Til Stürmer
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-10-07       Impact factor: 2.890

Review 6.  Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence.

Authors:  Tharaka Dassanayake; Patricia Michie; Gregory Carter; Alison Jones
Journal:  Drug Saf       Date:  2011-02-01       Impact factor: 5.606

Review 7.  Insomnia.

Authors:  Daniel J Buysse
Journal:  JAMA       Date:  2013-02-20       Impact factor: 56.272

Review 8.  Meta-analysis of the impact of 9 medication classes on falls in elderly persons.

Authors:  John C Woolcott; Kathryn J Richardson; Matthew O Wiens; Bhavini Patel; Judith Marin; Karim M Khan; Carlo A Marra
Journal:  Arch Intern Med       Date:  2009-11-23

9.  Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia.

Authors:  Charles M Morin; Célyne Bastien; Bernard Guay; Monelly Radouco-Thomas; Jacinthe Leblanc; Annie Vallières
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

10.  Benzodiazepine use and risk of Alzheimer's disease: case-control study.

Authors:  Sophie Billioti de Gage; Yola Moride; Thierry Ducruet; Tobias Kurth; Hélène Verdoux; Marie Tournier; Antoine Pariente; Bernard Bégaud
Journal:  BMJ       Date:  2014-09-09
View more
  5 in total

Review 1.  Accelerating Alzheimer's disease drug innovations from the research pipeline to patients.

Authors:  Dana P Goldman; Howard Fillit; Peter Neumann
Journal:  Alzheimers Dement       Date:  2018-04-18       Impact factor: 21.566

2.  Benzodiazepine use and the risk of dementia.

Authors:  Geoffrey Joyce; Patricia Ferido; Johanna Thunell; Bryan Tysinger; Julie Zissimopoulos
Journal:  Alzheimers Dement (N Y)       Date:  2022-07-20

3.  Minimally Adequate Treatment for Depression and Anxiety Associated With Mortality in Primary Care Older Adults.

Authors:  Helen-Maria Vasiliadis; Catherine Lamoureux-Lamarche; Sébastien Grenier; Pasquale Roberge
Journal:  Can J Psychiatry       Date:  2022-03-07       Impact factor: 5.321

Review 4.  Insomnia in the Older Adult.

Authors:  Glenna S Brewster; Barbara Riegel; Philip R Gehrman
Journal:  Sleep Med Clin       Date:  2017-11-22

5.  Geriatric Depression and Inappropriate Medication: Benefits of Interprofessional Team Cooperation in Nursing Homes.

Authors:  Hana Vankova; Iva Holmerova; Ladislav Volicer
Journal:  Int J Environ Res Public Health       Date:  2021-11-26       Impact factor: 3.390
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.